Use of asenapine in clinical practice for the management of bipolar mania.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 3, doi. 10.1177/1359786813482534
- By:
- Publication type:
- Article
Works matching IS 02698811 AND DT 2013 AND VI 27 AND IP 4
Results: 14
1
2
Management of schizophrenia: clinical experience with asenapine.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 14, doi. 10.1177/1359786813482533
- By:
- Publication type:
- Article
3
First episode psychosis patients show impaired cognitive function--a study of a South Asian population in the UK.
- Published in:
- 2013
- By:
- Publication type:
- journal article
4
Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
5
Comparison of the anti-dopamine D2 and anti-serotonin 5-HT2A activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 396, doi. 10.1177/0269881113478281
- By:
- Publication type:
- Article
6
Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 327, doi. 10.1177/0269881113477709
- By:
- Publication type:
- Article
7
Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 358, doi. 10.1177/0269881112473789
- By:
- Publication type:
- Article
8
Increases in triglyceride levels are associated with clinical response to clozapine treatment.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 401, doi. 10.1177/0269881112472568
- By:
- Publication type:
- Article
9
A review of anti-inflammatory agents for symptoms of schizophrenia.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 337, doi. 10.1177/0269881112467089
- By:
- Publication type:
- Article
10
First episode psychosis patients show impaired cognitive function – a study of a South Asian population in the UK.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 366, doi. 10.1177/0269881113477746
- By:
- Publication type:
- Article
11
Differential effects of antipsychotic agents on obsessive–compulsive symptoms in schizophrenia: a longitudinal study.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 349, doi. 10.1177/0269881112463470
- By:
- Publication type:
- Article
12
DRD2/ANKK1 Taq1A (rs 1800497 C>T) genotypes are associated with susceptibility to second generation antipsychotic-induced akathisia.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 343, doi. 10.1177/0269881112463469
- By:
- Publication type:
- Article
13
Reelin supplementation recovers sensorimotor gating, synaptic plasticity and associative learning deficits in the heterozygous reeler mouse.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 386, doi. 10.1177/0269881112463468
- By:
- Publication type:
- Article
14
Effects of antipsychotic treatment on cognition in healthy subjects.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 374, doi. 10.1177/0269881112466183
- By:
- Publication type:
- Article